CSIMarket
 


Genetic Technologies Limited  (GENE)
Other Ticker:  
 

Genetic Technologies Limited's Quick Ratio

GENE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




GENE Quick Ratio (Jun 30 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2018)
IV. Quarter
Y / Y Current Liabilities Change 2.92 % 2.92 % 2.92 % 2.92 % -
Y / Y Cash & cash equivalent Change -61.15 % -61.15 % -61.15 % -61.15 % -
Quick Ratio MRQ 1.43 1.43 1.43 1.43 3.78
Overall Ranking # # # # #
Seq. Current Liabilities Change 0 % 0 % 0 % 2.92 % 0 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % -61.15 % 0 %



Quick Ratio forth quarter 2019 Comment
Regardless of the sequential decrease in Current Liabilities, Quick Ratio detoriated to 1.43 below company average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry Genetic Technologies Limited booked the highest Quick Ratio than Genetic Technologies Limited in the forth quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are GENE Segments?
See Quick Ratio GENE on the trailing twelve month basis
Quick Ratio forth quarter 2019 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market # 0


Quick Ratio Statistics
High Average Low
3.78 2.61 1.43
(Jun 30 2018)   (Jun 30 2019)




Financial Statements
Genetic Technologies Limited's Current Liabilities $ 1 Millions Visit GENE's Balance sheet
Genetic Technologies Limited's Cash & cash equivalent $ 2 Millions Visit GENE's Balance sheet
Source of GENE's Sales Visit GENE's Sales by Geography


Cumulative Genetic Technologies Limited's Quick Ratio

GENE's Quick Ratio for the trailling 12 Months

GENE Quick Ratio

(Jun 30 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2018)
IV. Quarter
Y / Y Current Liabilities TTM Growth 2.92 % 2.92 % 2.92 % 2.92 % -
Y / Y Cash & cash equivalent TTM Growth -61.15 % -61.15 % -61.15 % -61.15 % -
Quick Ratio TTM 1.43 2 2.59 3.18 3.78
Total Ranking TTM # # # # #
Seq. Current Liabilities TTM Growth 0 % 0 % 0 % 2.92 % 0 %
Seq. Cash & cash equivalent TTM Growth 0 % 0 % 0 % -61.15 % 0 %


TTM Quick Ratio Comment
On the trailing twelve months basis Due to unchange in Current Liabilities in the IV. Quarter to $1.49 millions, average cumulative Quick Ratio decreased to 1.43 below the Genetic Technologies Limited average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry GENE achieved the highest Quick Ratio. While overall ranking remained unchanged compare to previous quarter at no. 0.

Explain Quick Ratio?
What are GENE Segments?
See Quick Ratio GENE on the trailing twelve month basis

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Within the Market # 0


TTM Quick Ratio Statistics
High Average Low
1.43 1.43 1.43
(Jun 30 2019)  




Companies with similar Quick Ratio in the quarter ending Jun 30 2019, within Biotechnology & Pharmaceuticals Industry Quick RatioJun 30 2019 MRQ Cash & cash equivalentJun 30 2019 MRQ Current Liabilities
Biondvax Pharmaceuticals Ltd   3.82 $ 72.467  Millions$ 18.959  Millions
Biontech Se  3.76 $ 582.294  Millions$ 154.719  Millions
Atyr Pharma Inc   3.75 $ 42.398  Millions$ 11.304  Millions
Cardiff Oncology inc   3.75 $ 10.791  Millions$ 2.878  Millions
Erytech Pharma S.a.  3.68 $ 81.954  Millions$ 22.267  Millions
Dbv Technologies S a   3.58 $ 192.670  Millions$ 53.836  Millions
Ocugen Inc   3.52 $ 2.786  Millions$ 0.791  Millions
Achieve Life Sciences Inc   3.50 $ 10.446  Millions$ 2.988  Millions
Natural Health Trends Corp   3.43 $ 108.106  Millions$ 31.528  Millions
Intuitive Surgical Inc   3.37 $ 2,718.400  Millions$ 807.500  Millions
Nexien Biopharma Inc   3.27 $ 0.146  Millions$ 0.045  Millions
Acorda Therapeutics inc   3.16 $ 297.082  Millions$ 93.951  Millions
Rewalk Robotics Ltd   3.11 $ 24.054  Millions$ 7.735  Millions
Alpha Pro Tech Ltd   3.03 $ 6.237  Millions$ 2.061  Millions
Armata Pharmaceuticals Inc   3.02 $ 13.192  Millions$ 4.370  Millions
Pluri Inc   2.99 $ 24.397  Millions$ 8.158  Millions
Meridian Bioscience Inc   2.78 $ 55.192  Millions$ 19.822  Millions
Coherus Biosciences inc   2.76 $ 111.968  Millions$ 40.576  Millions
Nanovibronix Inc  2.74 $ 2.371  Millions$ 0.865  Millions
Htg Molecular Diagnostics Inc  2.71 $ 21.567  Millions$ 7.960  Millions
Microbot Medical Inc   2.64 $ 11.632  Millions$ 4.406  Millions
Cel sci Corporation  2.64 $ 11.156  Millions$ 4.228  Millions
Mymd Pharmaceuticals Inc   2.64 $ 4.269  Millions$ 1.618  Millions
Lifeloc Technologies Inc   2.50 $ 2.535  Millions$ 1.012  Millions
Lineage Cell Therapeutics Inc   2.43 $ 16.687  Millions$ 6.859  Millions
Fate Therapeutics Inc   2.43 $ 71.435  Millions$ 29.418  Millions
Cidara Therapeutics Inc   2.40 $ 44.600  Millions$ 18.608  Millions
Bio rad Laboratories Inc   2.40 $ 987.416  Millions$ 412.044  Millions
Sienna Biopharmaceuticals, Inc.  2.36 $ 49.207  Millions$ 20.813  Millions
Halozyme Therapeutics Inc   2.23 $ 287.465  Millions$ 128.906  Millions

Date modified: 2022-08-31T08:21:00+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RH's Profile

Stock Price

RH's Financials

Business Description

Fundamentals

Charts & Quotes

RH's News

Suppliers

RH's Competitors

Customers & Markets

Economic Indicators

RH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071